LD-2 disclosure · 1st Quarter - Report
JAZZ PHARMACEUTICALS
Client
- Description
- ​Biopharmaceutical company.
- Location
- California · United States of America
Registrant
- Description
- Government Relations.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.
LobbyistsJOHN MICHAEL GONZALEZ · TIMOTHY A MOLINO · MATTHEW LEFFINGWELL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
Issues related to the FDA and S. 3032 - the FDA STATES Act (115th Congress), and Health and Human Services pertaining to CBD policies.
LobbyistsJOHN MICHAEL GONZALEZ · TIMOTHY A MOLINO · MATTHEW LEFFINGWELL
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
Appropriations issues related to Senate Amendment to H.R. 2471 - the Consolidated Appropriations Act of FY 2022 - pertaining to FDA enforcement of non-FDA approved CBD products.
LobbyistsJOHN MICHAEL GONZALEZ · TIMOTHY A MOLINO · MATTHEW LEFFINGWELL
TargetedSENATE · HOUSE OF REPRESENTATIVES